The surge of Japanese studies supporting the use of angiotensin receptor blockers in hypertension

Author： Kjeldsen Sverre   Narkiewicz Krzysztof   Hedner Thomas  

Publisher： Informa Healthcare

ISSN： 0803-7051

Source： Blood Pressure, Vol.18, Iss.5, 2009-10, pp. : 240-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin Receptor Blockers in Hypertension and Cardiovascular Diseases

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 4, Iss. 1, 2006-01 ,pp. : 67-73

Bentham Science Publishers

Access to resources Recommend Favorite

Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Treatment of Hypertension: Should they be Used Together?

By  

Current Vascular Pharmacology, Vol. 8, Iss. 6, 2010-11 ,pp. : 742-746

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Peroxisome Proliferator-Activated Receptor-γ Modulation in the Treatment of Hypertension and Metabolic Syndrome: The Role of Angiotensin II Receptor Blockers

By Borghi Claudio  

High Blood Pressure & Cardiovascular Prevention, Vol. 13, Iss. 3, 2006-01 ,pp. : 81-84

Adis International

Access to resources Recommend Favorite

2010 Position Paper of the Italian Society of Hypertension (SIIA): Angiotensin Receptor Blockers and Risk of Cancer

By Volpe Massimo   Morganti Alberto  

High Blood Pressure & Cardiovascular Prevention, Vol. 18, Iss. 1, 2011-03 ,pp. : 37-40

Adis International

Access to resources Recommend Favorite

Treating Hypertension with Angiotensin II Receptor Blockers: A Step Ahead of Blood Pressure Reduction?

By Ruilope Luis M.  

High Blood Pressure & Cardiovascular Prevention, Vol. 12, Iss. 1, 2005-01 ,pp. : 9-15

Adis International

Access to resources Recommend Favorite